Innovent Biologics
Tracked across 9 events · 60 articles · First seen May 08, 2026 · Last active Sep 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Innovent Biologics is the developer and co-commercializer of IBI363, and the positive long-term clinical trial results enhance its product pipeline and market position in oncology. The company's stock performance is likely to benefit from these favorable outcomes and the progression to global Phase 3 studies.
May 21, 2026 · 9 articles
Business
Impact: Innovent launched its GLP-1 drug and uses aggressive marketing, including subway ads and stadium promotions. Its product is gaining patient requests.
Aug 24, 2026 · 6 articles
Business
Impact: Innovent licensed SP001 to Spero, enabling Spero's immunology pipeline.
Jul 14, 2026 · 9 articles
Business
Impact: Innovent Biologics commercializes mazdutide in China, driving the royalty stream that underpins the financing. Its performance directly affects the value of the royalty interests.
Aug 13, 2026 · 6 articles
Regulatory
The United States — United States Department of the Treasury is drafting rules governing US pharmaceutical companies' investments in China that would likely preserve their ability to strike most licensing deals for Chinese drugs, according…
Impact: The Chinese biotech firm announced an up to $10.5 billion collaboration with Pfizer covering 12 oncology programs.
Sep 18, 2026 · 6 articles
Business
Impact: Collaborator of IASO Bio; unaffected directly.
Jul 20, 2026 · 6 articles
Business
Impact: Innovent Biologics is mentioned as a portfolio company of Legend Holdings, indicating the investor's expertise but not directly impacted.
Jul 20, 2026 · 6 articles
Business
Impact: Innovent is a partner of Ascentage Pharma, but this event does not directly involve Innovent.
Jul 26, 2026 · 6 articles
55
Pfizer announced collaboration Innovent BiologicsUS Treasury Drafts Pharma...
ERGEN INTELLIGENCE
Track Innovent Biologics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard